Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Nat Commun ; 15(1): 221, 2024 Jan 04.
Article in English | MEDLINE | ID: mdl-38177096

ABSTRACT

Lymphedema (LD) is characterized by the accumulation of interstitial fluid, lipids and inflammatory cell infiltrate in the limb. Here, we find that LD tissues from women who developed LD after breast cancer exhibit an inflamed gene expression profile. Lipidomic analysis reveals decrease in specialized pro-resolving mediators (SPM) generated by the 15-lipoxygenase (15-LO) in LD. In mice, the loss of SPM is associated with an increase in apoptotic regulatory T (Treg) cell number. In addition, the selective depletion of 15-LO in the lymphatic endothelium induces an aggravation of LD that can be rescued by Treg cell adoptive transfer or ALOX15-expressing lentivector injections. Mechanistically, exogenous injections of the pro-resolving cytokine IFN-ß restores both 15-LO expression and Treg cell number in a mouse model of LD. These results provide evidence that lymphatic 15-LO may represent a therapeutic target for LD by serving as a mediator of Treg cell populations to resolve inflammation.


Subject(s)
Arachidonate 15-Lipoxygenase , Lymphedema , Humans , Mice , Female , Animals , Arachidonate 15-Lipoxygenase/genetics , Arachidonate 15-Lipoxygenase/metabolism , Inflammation/metabolism , Cytokines/metabolism , T-Lymphocytes, Regulatory/metabolism
2.
Actas urol. esp ; 46(2): 106-113, mar. 2022. tab
Article in Spanish | IBECS | ID: ibc-203561

ABSTRACT

Introducción y objetivoAunque los comités multidisciplinares (CMD) están recomendados en el manejo del cáncer de próstata avanzado (CPA), su funcionamiento en práctica real se ha evaluado escasamente. Desarrollamos un estudio multicéntrico con el objetivo de evaluar el funcionamiento de los CMD urooncológicos en seis hospitales.Materiales y métodosRealizamos un estudio transversal descriptivo. El nivel de cumplimiento de los requisitos de calidad fundamentales (CRCF) de los CMD, se evaluó aplicando un cuestionario a los coordinadores de los CMD de cada hospital. La perspectiva de los miembros de los CMD se evaluó aplicando una encuesta anónima telemática.ResultadosEvidenciamos un alto nivel de CRCF en los CMD (75%), mostrando deficiencias en la actualización de protocolos, agendas, auditorías y producción científica. La encuesta fue respondida por un 62,32% de los 69 médicos encuestados (urólogos, oncólogos, radioterapéutas, radiólogos y anatomopatólogos). El 88,4% considera adecuado el tiempo de las reuniones. Existen opiniones dispares sobre la protección del tiempo de las reuniones y la actualización de protocolos. El 62,8% de los pacientes presentados requieren la intervención de dos especialidades. La mitad de los encuestados cree que se discuten todos los casos de CPRC y que existe una agenda previa. Las decisiones del CMD quedan reflejadas en la historia clínica en un 65,1% y son vinculantes en un 60,5%. La mitad de los encuestados niegan capacitación en CMD. La mayoría de los participantes (90,7%) avalan los beneficios de los CMD.ConclusionesLas evaluaciones de los CMD identifican deficiencias subsanables modificando la inercia hospitalaria y la planificación asistencial (AU)


Introduction and objectiveAlthough Multidisciplinary Teams (MDTs) are recommended in the management of Advanced Prostate Cancer (APC), their functioning in real practice has been poorly evaluated. We carried out a multicenter study with the objective of evaluating the functioning of uro-oncology MDTs in 6 hospitals.Materials and methodsA descriptive cross-sectional study was performed. The level of Compliance with the Fundamental Quality Requirements (CFQR) of the MDTs was evaluated by means of a questionnaire filled out by the coordinators of the MDTs in each hospital. The information on the perspective of the members of the MDTs was evaluated through an anonymous survey.ResultsA high level of CFQR in MDTs was evidenced (75%), showing deficiencies in terms of protocol update, agendas, audits, and scientific production. The survey was answered by 62.32% of the 69 physicians surveyed (urologists, oncologists, radiation therapists, radiologists, and pathologists). The 88.4% consider the duration of the meetings appropriate. There are disparate opinions concerning the protection of the MDT meeting time as well as protocol update. Of the patients with APC presented at the MDTs meeting, 62,8% require intervention from two specialties. Only 50% of respondents believe that all CRPC cases are discussed and that there is a prior agenda. The decisions made by the MDTs are reflected in the clinical history in 65.1% and are binding only in 60.5% of the cases. Half of the respondents have not been trained in MDTs. Most participants (90.7%) agree on the fact that MDTs. convey benefits.ConclusionsThe evaluations of the MDTs identify rectifiable deficiencies by modifying hospital inertia and care planning (AU)


Subject(s)
Humans , Male , Prostatic Neoplasms/therapy , Professional Staff Committees , Patient Care Team , Cross-Sectional Studies , Medical Oncology
3.
Actas Urol Esp (Engl Ed) ; 46(2): 106-113, 2022 Mar.
Article in English, Spanish | MEDLINE | ID: mdl-35135737

ABSTRACT

INTRODUCTION AND OBJECTIVE: Although Multidisciplinary Teams (MDTs) are recommended in the management of Advanced Prostate Cancer (APC), their functioning in real practice has been poorly evaluated. We carried out a multicenter study with the objective of evaluating the functioning of uro-oncology MDTs in 6 hospitals. MATERIALS AND METHODS: A descriptive cross-sectional study was performed. The level of Compliance with the Fundamental Quality Requirements (CFQR) of the MDTs was evaluated by means of a questionnaire filled out by the coordinators of the MDTs in each hospital. The information on the perspective of the members of the MDTs was evaluated through an anonymous survey. RESULTS: A high level of CFQR in MDTs was evidenced (75%), showing deficiencies in terms of protocol update, agendas, audits, and scientific production. The survey was answered by 62.32% of the 69 physicians surveyed (urologists, oncologists, radiation therapists, radiologists, and pathologists). The 88.4% consider the duration of the meetings appropriate. There are disparate opinions concerning the protection of the MDT meeting time as well as protocol update. Of the patients with APC presented at the MDTs meeting, 62,8% require intervention from two specialties. Only 50% of respondents believe that all CRPC cases are discussed and that there is a prior agenda. The decisions made by the MDTs are reflected in the clinical history in 65.1% and are binding only in 60.5% of the cases. Half of the respondents have not been trained in MDTs. Most participants (90.7%) agree on the fact that MDTs. convey benefits. CONCLUSIONS: The evaluations of the MDTs identify rectifiable deficiencies by modifying hospital inertia and care planning.


Subject(s)
Patient Care Team , Prostatic Neoplasms , Cross-Sectional Studies , Humans , Male , Medical Oncology , Prostatic Neoplasms/therapy , Urologists
5.
Urol Res ; 40(5): 575-9, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22555869

ABSTRACT

Patient collaboration in external shock wave lithotripsy (ESWL) is critical for its correct application, making proper analgesic selection indispensable. The aim of this study was to evaluate the efficacy of combined application of EMLA and intravenous (i.v.) pethidine compared with pethidine plus placebo cream in patients undergoing ESWL for ureteral and/or renal lithiasis. Prospective, controlled, randomized, double-blind study was conducted in patients receiving ESWL for renal and/or ureterolithiasis. The patients were randomly assigned to receive i.v. pethidine plus either EMLA cream (group A) or placebo hydrating cream (group B). Evaluated were type, location, and size of lithiasis, patient's sex, age, body mass index, comorbidity, Visual Analogue Scale (VAS) score of pain, and degree of lithiasis fragmentation. EMLA cream provided significantly better pain relief and lithiasis fragmentation and more completed ESWL treatment. Topical application of EMLA cream combined with i.v. pethidine improved VAS scores and lithiasis fragmentation and decreased the rate of withdrawal from ESWL procedure versus i.v. pethidine plus placebo therapy.


Subject(s)
Anesthetics, Combined/therapeutic use , Lidocaine/therapeutic use , Lithotripsy , Pain/drug therapy , Prilocaine/therapeutic use , Adult , Aged , Body Mass Index , Double-Blind Method , Female , Humans , Lidocaine, Prilocaine Drug Combination , Male , Meperidine/administration & dosage , Middle Aged , Pain Measurement , Prospective Studies
6.
Obstet Gynecol ; 91(5 Pt 2): 850-2, 1998 May.
Article in English | MEDLINE | ID: mdl-9572188

ABSTRACT

BACKGROUND: Lymphocytic hypophysitis is an unusual autoimmune disease that causes partial or total hypopituitarism and often is associated with pregnancy. Only four spontaneous pregnancies have been reported after this disease. We report a case of ovulation induction in a woman with this antecedent as well as the course of the subsequent pregnancy. CASE: Ovulation was induced with gonadotropins in a 31-year-old woman with panhypopituitarism secondary to lymphocytic hypophysitis, achieving an uncomplicated single intrauterine pregnancy. A term healthy infant was delivered by cesarean. Clinical course during puerperium was normal. CONCLUSION: Ovulation induction response was similar to that in panhypopituitarism of any other cause. Lymphocytic hypophysitis antecedent did not adversely affect pregnancy outcome nor was pregnancy-related disease relapse observed.


Subject(s)
Hypopituitarism/etiology , Infertility, Female/therapy , Lymphocytes/pathology , Ovulation Induction , Pituitary Gland/pathology , Pregnancy , Adult , Female , Humans , Hypopituitarism/therapy , Infertility, Female/complications , Lymphocytosis , Pituitary Diseases/complications , Pituitary Diseases/pathology , Pregnancy Complications/therapy
SELECTION OF CITATIONS
SEARCH DETAIL